Search

Your search keyword '"Antigens, CD34 immunology"' showing total 1,255 results

Search Constraints

Start Over You searched for: Descriptor "Antigens, CD34 immunology" Remove constraint Descriptor: "Antigens, CD34 immunology" Language english Remove constraint Language: english
1,255 results on '"Antigens, CD34 immunology"'

Search Results

2. Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial.

3. Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome.

4. Lentiviral Gene Therapy for Artemis-Deficient SCID.

5. Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.

6. An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.

7. Acute myeloid leukemia with cup-like blasts and FLT3-ITD and NPM1 mutations mimics features of acute promyelocytic leukemia: a case of durable remission after sorafenib and low-dose cytarabine.

8. Prospective Isolation and Characterization of Chondroprogenitors from Human Chondrocytes Based on CD166/CD34/CD146 Surface Markers.

9. Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis.

10. Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

11. CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update.

12. An in vitro platform supports generation of human innate lymphoid cells from CD34 + hematopoietic progenitors that recapitulate ex vivo identity.

13. Evaluation of circulating CD34+ stem cells in peripheral venous blood in patients with varying degrees of periodontal disease.

14. CD34+ derived macrophage and dendritic cells display differential responses to paraquat.

15. Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patients.

16. DL4-μbeads induce T cell lineage differentiation from stem cells in a stromal cell-free system.

17. CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study.

18. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.

19. Evaluation of glycolytic rates in human hematopoietic stem/progenitor cells after target gene depletion.

20. Efficacy of a conversion from filgrastim to filgrastim-sndz in stem cell transplant patients undergoing mobilization.

21. New lymphatic cell formation is associated with damaged brain tissue clearance after penetrating traumatic brain injury.

22. Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review.

23. Human Cytomegalovirus miR-US25-1 Targets the GTPase RhoA To Inhibit CD34 + Hematopoietic Progenitor Cell Proliferation To Maintain the Latent Viral Genome.

24. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.

25. Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34 - and immature CD34 +  cells.

26. Diabetes Induces a Transcriptional Signature in Bone Marrow-Derived CD34 + Hematopoietic Stem Cells Predictive of Their Progeny Dysfunction.

27. Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34 + Hematopoietic Progenitor Cells from Apoptosis.

28. Hematological Humanization of Immune-Deficient Mice.

29. CD34 + stem cell counting using labeled immobilized anti-CD34 antibody onto magnetic nanoparticles and EasyCounter BC image cytometer.

30. Evaluation of Mast Cell Density using CD117 antibody and Microvessel Density Using CD34 Antibody in Different Grades of Oral Squamous Cell Carcinoma.

31. Role of fibrocytes and endothelial progenitor cells among low-differentiated CD34+ cells in the progression of lung sarcoidosis.

32. Lack of CD34 produces defects in platelets, microparticles, and lung inflammation.

33. Effect of Tussilago farfara L. Polysaccharides on the Content of Hematopoietic Stem Cells (CD117 + 34 + ) in the Bone Marrow of Mice Treated with Cyclophosphamide.

34. Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer.

35. Myelopoiesis specific gene expression profiling in human CD34 + hematopoietic stem cells.

36. Processing Human Thymic Tissue for Single Cell RNA-Seq.

37. Conjugating heparin, Arg-Glu-Asp-Val peptide, and anti-CD34 to the silanic Mg-Zn-Y-Nd alloy for better endothelialization.

38. Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies.

39. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.

40. Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage.

41. Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis.

42. Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo.

43. Superficial CD34-Positive Fibroblastic Tumor: A Case Report and Review of the Literature.

44. Myxoid Fibrolipoma: Case series of a lipoma variant with myxoid stroma and dense fibrous tissue.

45. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.

46. An atypical pleomorphic lipomatous tumor arising on the cheek.

47. Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34 + cells.

48. Progenitor cell combination normalizes retinal vascular development in the oxygen-induced retinopathy (OIR) model.

49. Enhanced Transduction of Macaca fascicularis Hematopoietic Cells with Chimeric Lentiviral Vectors.

50. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.

Catalog

Books, media, physical & digital resources